| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protara Therapeutics, Inc. (TARA) has 14 insiders with recent SEC Form 4 filings, including 6 buys and 6 sells. TARA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 524.0K | $2.72M | - | |
| CFO | 175.0K | $910.0K | - | |
| Other | 158.0K | $821.6K | - | |
| Other | 94.8K | $493.1K | - | |
| Other | 76.0K | $395.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2017 | Flynn James E62 | Director, *director By Deputization | Buy | 110,557 | $1.75 | $193,474.75 | +127.3% | |
| Nov 14, 2017 | Eldridge, George Arthur | Sr VP, CFO, Treasr, Asst Secy | Buy | 295 | $1.69 | $498.55 | +23.6% | |
| Jun 6, 2016 | Eldridge, George Arthur | Sr VP, CFO, Treasurer, Sec. | Buy | 4,000 | $5.78 | $23,109.80 | New | |
| Jan 4, 2016 | Noyes Timothy P81 | President And CEO | Sale+OE | 5,000 | $13.88 | $69,400.00 | -100% | |
| Dec 1, 2015 | Noyes Timothy P81 | President And CEO | Sale+OE | 5,000 | $14.97 | $74,850.00 | -100% | |
| Nov 2, 2015 | Noyes Timothy P81 | President And CEO | Sale+OE | 5,000 | $13.50 | $67,500.00 | -100% | |
| Oct 1, 2015 | Noyes Timothy P81 | President And CEO | Sale+OE | 5,000 | $13.33 | $66,650.00 | -100% | |
| Sep 8, 2015 | Noyes Timothy P81 | President And CEO | Sale+OE | 5,000 | $13.55 | $67,750.00 | -100% | |
| Jul 7, 2015 | Gottlieb Daniel Philip | VP Marketing &Bus Development | Sell | 1,965 | $16.86 | $33,129.90 | -100% |